skip navigation

S M L Text size

Retinopathy of prematurity (ROP) is a potentially blinding eye disorder that primarily affects premature infants weighing about 2¾ pounds (1250 grams) or less that are born before 31 weeks of gestation.

Home » Health Information » Retinopathy of Prematurity

Retinopathy of Prematurity

Patient Information

Research Highlights

Results

News and Press Releases

Videos

Other Helpful Links







*PDF files require the free Adobe® Reader® software for viewing. Attention people with visual disabilities: please visit access.adobe.com to work more effectively with PDF files. On this website, a file size will be indicated when exceeding 1M. Need help working with PDF files?

 

This page was last modified in February 2010

[ NEI Home | Contact Us | A-Z Site Map | Information in Spanish (Información en español)]
[ Web Site Policies and Important Links | Privacy Policy | FOIA | Information Quality Guidelines | FAQ ]

We welcome your questions and comments. Please send general questions and comments to the NEI Office of Communication, Health Education, and Public Liaison. Technical questions about this website can be addressed to the NEI Website Manager.


U. S. Department of Health and Human Services

National Institutes of Health

USA.gov


National Eye Institute
2020 Vision Place
Bethesda, MD 20892-3655
(301) 496-5248
www.nei.nih.gov

NEI Website Header Description: Confocal image of rat RPE layer two weeks after laser. A well-defined neovascular membrane labeled with Isolectin Ib4 (red) is detected below proliferating RPE cells (Phalloidin in green). New vessels are growing toward the subretinal space.